Gamma-Hydroxybutyrate: effects on nonstriatal dopaminergic neurons
Roth, R.H.; Nowycky, M.C.; Walters, J.R.; Morgenroth, V.H.
Advances in Biochemical Psychopharmacology 16: 483-488
1977
ISSN/ISBN: 0065-2229 PMID: 18897 Document Number: 116578
Document emailed within 1 workday
Related Documents
Bunney, W.E. 1977: Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases Advances in Biochemical Psychopharmacology 16: 635-637Roth, R.H.; Nowycky, M.C. 1977: Nonstriatal dopaminergic neurons: role of presynaptic receptors in the modulation of transmitter synthesis Advances in Biochemical Psychopharmacology 16: 465-470
Mamelak, M.; Escriu, J.M.; Stokan, O. 1977: The effects of gamma-hydroxybutyrate on sleep Biological Psychiatry 12(2): 273-288
Pierrefiche, G.; Topall, G.; Henriet, I.; Laborit, H. 1991: Protective effects of gamma-hydroxybutyrate on alloxan induced diabetes in mice Research Communications in Chemical Pathology and Pharmacology 71(3): 309-319
Murrin, L.C.; Morgenroth, V.H.; Roth, R.H. 1976: Dopaminergic neurons: effects of electrical stimulation on tyrosine hydroxylase Molecular Pharmacology 12(6): 1070-1081
Murrin, L.C.; Roth, R.H. 1976: Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis Molecular Pharmacology 12(3): 463-475
Oyama, T.; Takiguchi, M. 1970: Effects of gamma-hydroxybutyrate and surgery on plasma human growth hormone and insulin levels Agressologie 11(3): 289-298
Roth, R.H.; Walters, J.R.; Morgenroth, V.H. 1974: Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons Advances in Biochemical Psychopharmacology 12: 369-384
Hulley, P.; Hartikka, J.; Lübbert, H. 1995: Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+ Journal of Neural Transmission. Supplementum 46: 217-228
Liu, W.; Shen, M.; Xiang, P.; Bu, J.; Wu, H.-J. 2007: Detection of gamma-hydroxybutyrate (GHB) in beverages Fa Yi Xue Za Zhi 23(2): 120-122; 129
Strand, N.A.W.; Petersen, T.S.; Nielsen, L.M.; Boegevig, S. 2017: Treatment of gamma-hydroxybutyrate withdrawal Ugeskrift for Laeger 179(50)
Escuret, E. 1991: Sodium gamma-hydroxybutyrate. Certainties and therapeutic potentialities Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 32(8-9 Spec No): 417-426
Sierra Córcoles, R.; Alemany Esteban, F. 1979: Anesthesia with gamma hydroxybutyrate in patients with acute hepatopathies Revista Espanola de Anestesiologia y Reanimacion 26(2): 127-136
DeFeudis, F.V.; Collier, B. 1970: Amino acids of brain and gamma-hydroxybutyrate-induced depression Archives Internationales de Pharmacodynamie et de Therapie 187(1): 30-36
Laborit, G.; Baron, C.; Topal, G.; Henriet, I. 1980: Value of sodium gamma hydroxybutyrate in cerebral protection during severe hypoxia in the rat Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 21(4): 189-197
Gherbassi, D.; Simon, H.H. 2006: The engrailed transcription factors and the mesencephalic dopaminergic neurons Journal of Neural Transmission. Supplementum 2006(70): 47-55
Zhu, W.J.; Wang, J.F.; Vicini, S.; Grayson, D.R. 1996: Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons Molecular Pharmacology 50(1): 23-33
Christensen, H.R. 1999: Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate Ugeskrift for Laeger 161(50): 6899
Ogawa, N.; Edamatsu, R.; Mizukawa, K.; Asanuma, M.; Kohno, M.; Mori, A. 1993: Degeneration of dopaminergic neurons and free radicals. Possible participation of levodopa Advances in Neurology 60: 242-250
Di Giovanni, G.; Di Matteo, V.; Esposito, E. 2009: Birth, life and death of dopaminergic neurons in the substantia nigra Journal of Neural Transmission. Supplementum 73: 1 P Preceeding Table of Contents